Middle East and Africa Hemostasis Analyzers Market is expected to reach US$ 251.51 Million by 2028


PRESS RELEASE BY The Insight Partners 11 Feb 2022

Share this press on


 Laboratory Analyzer segment has the Largest Share of Product Type in the Middle East and Africa Hemostasis Analyzers Market during 2020–2028 

According to The Insight Partners market research study on “Middle East and Africa Hemostasis Analyzers Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Test, End User and Country” is expected to reach US$  251.51 million by 2028 from US$  140.69 million in 2021. The market is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.

The pandemic has increased the demand for medical devices that can be used in a home care setting. The region has observed increasing numbers of patients admitted to intensive care units (ICU). A rising number of medications imposing multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices and pharmaceuticals. Also, the increasing number of cases of chronic conditions has increased, which resulted in an increased use of drugs for combating the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of certain blood pressure medications such as angiotensin converting enzyme inhibitors (ACEi) and angiotensin-converting blockers (ARB). The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptors to facilitate entry into the host cell. This pandemic enhanced the business operation of the various drug manufacturers operating in the hemostasis analyzers market in the region.

The market for Middle East and Africa Hemostasis Analyzers Market is segmented into the product type, test, end user and country. Based on product type, the Middle East and Africa Hemostasis Analyzers Market is segmented into laboratory analyzer, and point-of-care testing systems, whereas laboratory analyzer sub segmented   into automated systems, semi-automated systems, and manual systems. In 2021, the laboratory analyzer segment accounted for the largest market share. The growth of these segments is attributed to an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases, development of point of care (POC) coagulation testing, and the surge in laboratory automation is likely to create opportunity in the forecast year. However the point-of-care testing systems segment is estimated to register the highest CAGR during the forecast period.

Siemens Healthineers AG, Abbott, Sysmex Corporation, Nihon Kohden Corporation, THERMO FISHER SCIENTIFIC INC., HOFFMANN-LA ROCHE LTD., Instrumentation Laboratory Company. Among the leading companies in the Middle East and Africa hemostasis analyzers market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for Middle East and Africa hemostasis analyzers market is segmented into product type, test, and end user. Based on product type, the Middle East and Africa hemostasis analyzers market is segmented into laboratory analyzer [automated systems, semi-automated systems, and manual systems], and point-of-care testing systems. Based on test, the Middle East and Africa hemostasis analyzers market is segmented into activated partial thromboplastin time, d-dimer test, fibrinogen test, prothrombin time (PT) test, and others. Based on end user, the Middle East and Africa hemostasis analyzers market is segmented into hospitals/ clinics, independent diagnostic laboratories, home care setting, and others. By Geographically, Middle East and Africa hemostasis analyzers market is segmented into (Saudi Arabia, South Africa, UAE and Rest of Middle East and Africa).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

 

Download Free PDF Brochure